FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

Managing a modern pharmaceutical supply chain is like building a house during a storm; it is no longer enough to ensure the ...

Frits Stulp, Implement Consulting, says AI and global collaboration are key to addressing patent cliffs and accelerating ...

André Cerbe, CEO of Schlafender Hase, spoke with Pharmaceutical Technology® about the disruptions the pharma industry faced ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

On Dec. 19, 2025, Emer Cooke, executive director of the European Medicines Agency (EMA), published highlights of the agency’s accomplishments in 2025, which marked three decades since its inception.

Pharmaceutical manufacturing sustainability issues include energy use, GHG emissions, waste management, and pharmaceutical pollution affecting ecosystems. Companies can enhance sustainability by ...